covance 050218 AVCT… XXXX Fell to lows of 15.25p 6th November 2019… spike up yesterday 7th Nov 20% to 17p
covance 050218 AVCT… XXXX Keeps falling but still above my previous top up .
covance 050218 AVCT… XXXX Marked down 10% this morning and news of it , must all be in spread as still 34p . Poor RNS the reason .
covance 050218 AVCT… XXXX Dropped back down last month from high of 45p … now 34p
Avacta presentation at ShareSoc 13.3.19 Avacta presentation at ShareSoc London 13.3.19 by Dr Alastair Smith [link] Dr Smith gives a comprehensive overview of AVCT, followed by the Q&A.
3% Shareholders Significant Shareholdings Current significant shareholders are as follows: IP Group plc – 17.16% J O Hambro – 10.91% Baillie Gifford & Co Limited – 8.54% Lombard Odier Asset Management – 7.99% Carlton Holdings International – 7.28% Fidelity - 5.89% Ruffer LLP – 3.72% Unicorn Asset Management – 3.46% Mole Valley Asset Management – 3.01% As at 28th February 2019 the company has 115,835,037 ordinary shares of 10p each in issue. 32.3% of the ordinary shares of the Company are not held in public hands. and aviva below reporting threshold so if a persistent seller presumably them as all others the same mol
Businessweekly Awards 2019 Phoremost also shortlisted [link] mol
General Update re agm Have you seen the write up by Hardman and Co?
General Update re agm oops meant to add change of accounting ref date RNS 180119 Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents announces that it has changed its accounting reference date from 31 July to 31 December with immediate effect. As a result of the change of accounting reference date the Company’s reporting calendar will be as follows: Unaudited interim accounts for the 6 month period ended 31 January 2019 to be published by 30 April 2019. Publication of unaudited accounts for the 12 month period ended 31 July 2019 to be published by 31 October 2019 and publication of audited final accounts for the 17 month period ended 31 December 2019 to be published by 31 May 2020. Thereafter, interim and annual reports will be published each year for the 6 months to 30 June and 12 months to 31 December respectively, in accordance with the AIM Rules for Companies. [link] methinks due to timing of forecasted revenue flow - but perhaps not as publication of info in interim in line with aim rules ie within 3 months of end of relevant period anyway this company is usually either on time or ahead of aim rules in general mol
General Update re agm btw the two largest trades of the day on london stock exchange 14:40:24 30-Jan-2019 43.33 GBX 95,000 41,163.50 Off-book LRGS AIMX 14:37:11 30-Jan-2019 42.00 GBX 200,000 84,000.00 Off-book AIM mol
General Update re agm Proactiveinvestors UK Avacta's Alastair Smith encouraged by significant progress and share price... Alastair Smith, chief executive of Avacta Group PLC (LON:AVCT), caught up with Proactive London's Andrew Scott to talk through a business update released from the firm to coincide with its annual general meeting this week. slides re agm [link] and recent independent published paper MDPI Toxin Neutralization Using Alternative Binding Proteins Animal toxins present a major threat to human health worldwide, predominantly through snakebite envenomings, which are responsible for over 100,000 deaths each year. To date, the only available treatment against snakebite envenoming is plasma-derived... also very happy with improvement in sp - but not with my non-top decision at c 24p lol considering top up though at this level just thought i would also like to put avacta at top of discussion list tonight! mol mol
covance 050218 AVCT… XXXX Been slowly climbing above 39p today .
3% Shareholders aviva rns 121218 5.67% to 3.92% 6546707 to 4529623 111218 but only today rns re same date threshold changed again and avacta notified! nevermind for the record and completeness 3.92% to 2.43% 4529623 to 2810729 no of shares now held mol